Several studies demonstrated that IL-1α/β [41–43], IL-6 [44, 45], GM-CSF [46] and MIP-1α [47, 48] exert positive regulatory effects to expand primitive CML cells. This evidence concerns the gene CSF2 and chronic myelogenous leukemia, BCR-ABL1 positive.